Nextcure logo

Nextcure Share Price Today

(NASDAQ: NXTC)

Nextcure share price is $0.74 & ₹64.36 as on 6 Mar 2025, 2.30 'hrs' IST

$0.74

Market is closed - opens 8 PM, 06 Mar 2025

View live Nextcure share price in Dollar and Rupees. Guide to invest in Nextcure stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nextcure, along with analyst recommendations, forecasts, and comprehensive financials.

Nextcure share price movements

  • Today's Low: $0.70
    Today's High: $0.78

    Day's Volatility :10.12%

  • 52 Weeks Low: $0.66
    52 Weeks High: $2.57

    52 Weeks Volatility :74.31%

Nextcure (NXTC) Returns

PeriodNextcure IncIndex (Russel 2000)
3 Months
-32.2%
0.0%
6 Months
-48.68%
0.0%
1 Year
-56.14%
0.0%
3 Years
-84.51%
-11.6%

Nextcure (NXTC) Key Statistics

in dollars & INR

Previous Close
$0.739
Open
$0.7431
Today's High
$0.7799
Today's Low
$0.701
Market Capitalization
$20.4M
Today's Volume
$7.0K
52 Week High
$2.57
52 Week Low
$0.6603
Revenue TTM
$0.0
EBITDA
$-57.5M
Earnings Per Share (EPS)
$-2.1
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-57.93%

How to invest in Nextcure Stock (NXTC) from India?

It is very easy for Indian residents to invest directly in Nextcure from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nextcure stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nextcure or NXTC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nextcure or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nextcure shares which would translate to 1.175 fractional shares of Nextcure as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nextcure, in just a few clicks!

Returns in Nextcure (NXTC) for Indian investors in Rupees

The Nextcure stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nextcure investment value today

Current value as on today

₹48,750

Returns

₹51,250

(-51.25%)

Returns from Nextcure Stock

₹56,213 (-56.21%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Nextcure (NXTC)

-33%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nextcure Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Nextcure

  • Sofinnova Ventures

    9.54%

  • Affinity Asset Advisors, LLC

    8.22%

  • Citigroup Inc

    4.96%

  • Orbimed Advisors, LLC

    4.07%

  • Vanguard Group Inc

    3.53%

  • BlackRock Inc

    2.60%

Analyst Recommendation on Nextcure

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Nextcure(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Nextcure Stock (NXTC)

What analysts predicted

Upside of 372.97%

Target:

$3.50

Current:

$0.74

Insights on Nextcure Stock (Ticker Symbol: NXTC)

  • Price Movement

    In the last 6 months, NXTC stock has moved down by -48.7%
  • NXTC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 123.4%
  • NXTC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 132.2%

Nextcure Technicals Summary

Sell

Neutral

Buy

Nextcure is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Nextcure (NXTC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nextcure Inc logo
-4.34%
-48.68%
-56.14%
-84.51%
-98.13%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nextcure Inc logo
NA
NA
NA
-1.94
-0.58
-0.33
NA
2.7
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nextcure Inc logo
Buy
$20.4M
-98.13%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Nextcure

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company is developing NC410, an immunomedicine designed to block immune suppression mediated by LAIR-1; NC762, a monoclonal antibody that binds specifically to B7-H4, a protein expressed on multiple tumor types; and NC525, a monoclonal antibody that binds to LAIR-1 to functionally kill AML blast cells and leukemic stem cells while preserving normal blood cells, including hematopoietic stem cells. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. It has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
Organization
Nextcure
Employees
82
CEO
Mr. Michael S. Richman MSBA
Industry
Biotechnology

Management People of Nextcure

NameTitle
Mr. Michael S. Richman MSBA
Co-Founder, CEO, President & Director
Dr. Solomon Langermann Ph.D.
Chief Scientific Officer
Dr. Lieping Chen M.D., Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Mr. Steven P. Cobourn CPA
Chief Financial Officer
Dr. Timothy Mayer Ph.D.
Chief Operating Officer
Mr. Kevin G. Shaw
Senior VP & General Counsel
Mr. Sourav Kundu Ph.D.
Senior Vice President of Development & Manufacturing
Dr. Sebastien Maloveste Ph.D.
Senior Vice President of Business Development
Dr. Udayan Guha M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in NXTC Stock from India :

What is Nextcure share price today?

Nextcure share price today stands at $0.74, Open: $0.74 ; Previous Close: $0.74 ; High: $0.78 ; Low: $0.70 ; 52 Week High: $2.57 ; 52 Week Low: $0.66.

The stock opens at $0.74, after a previous close of $0.74. The stock reached a daily high of $0.78 and a low of $0.70, with a 52-week high of $2.57 and a 52-week low of $0.66.

Can Indians buy Nextcure shares?

Yes, Indians can invest in the Nextcure (NXTC) from India.

With INDmoney, you can buy Nextcure at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nextcure at zero transaction cost.

How can I buy Nextcure shares from India?

It is very easy to buy Nextcure from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nextcure (NXTC) be purchased?

Yes, you can buy fractional shares of Nextcure with INDmoney app.

What are the documents required to start investing in Nextcure stocks?

To start investing in Nextcure, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nextcure Stock (NXTC)?

Today’s highest price of Nextcure (NXTC) is $0.78.

Today’s lowest price of Nextcure (NXTC) is $0.70.

What is today's market capitalisation of Nextcure?

Today's market capitalisation of Nextcure NXTC is 20.4M

What is the 52 Week High and Low Range of Nextcure Stock (NXTC)?

  • 52 Week High

    $2.57

  • 52 Week Low

    $0.66

What are the historical returns of Nextcure (NXTC)?

  • 1 Month Returns

    -4.34%

  • 3 Months Returns

    -48.68%

  • 1 Year Returns

    -56.14%

  • 5 Years Returns

    -98.13%

Who is the Chief Executive Officer (CEO) of Nextcure ?

Mr. Michael S. Richman MSBA is the current Chief Executive Officer (CEO) of Nextcure.